Designing epidemiological studies to estimate the incidence of thrombosis in patients with antiphospholipid syndrome with history of recurrent thrombotic event
Changes in hemoglobin measures observed in PNH patients treated with both c5 inhibitors ravulizumab and eculizumab: real-world evidence from a US-Based EMR network
Real-world healthcare utilization and clinical markers preceding dialysis in patients with primary hyperoxaluria (PH) in the United States (PO1317)
